Treatment of generalized granuloma annulare with dupilumab

J Dermatolog Treat. 2023 Dec;34(1):2186158. doi: 10.1080/09546634.2023.2186158.

Authors

Xiaoting Song¹, Zirui Chen¹, Zuotao Zhao¹, Aiping Wang¹

Affiliation

¹ Beijing Key Laboratory of molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China.

PMID: 36856458
DOI: 10.1080/09546634.2023.2186158

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized
Granuloma Annulare*
Humans

Substances

dupilumab
Antibodies, Monoclonal, Humanized